Coppes M J, Egeler R M
Southern Alberta Children's Cancer Program, Alberta Children's Hospital and Tom Baker Cancer Centre, Calgary, Canada.
Semin Urol Oncol. 1999 Feb;17(1):2-10.
The molecular genetic characterization of Wilms' tumor has played a prominent role in advancing our knowledge of the genetic aspects underlying the development of cancer in general. Unlike the genetic mechanism leading to the development of retinoblastoma, an embryonal tumor of childhood affecting the retina, which only requires the inactivation of one single gene, the biological pathways leading to the development of Wilms' tumor are complex and likely involve several genetic loci. These include two genes on chromosome 11p; one on chromosome 11p13 (the Wilms' tumor suppressor gene WT1) and the other on chromosome 11p15 (the putative Wilms' tumor suppressor gene WT2). In addition to these two genes, loci at 1p, 7p, 16q, 17p (the p53 tumor suppressor gene), and 19q (the putative familial Wilms' tumor gene FWT2) are also believed to harbor genes involved in the biology of Wilms' tumor. Herein these loci are reviewed and their clinical significance is summarized.
肾母细胞瘤的分子遗传学特征在推动我们对癌症发生发展的遗传基础的总体认识方面发挥了重要作用。与导致视网膜母细胞瘤(一种影响视网膜的儿童胚胎性肿瘤)发生的遗传机制不同,视网膜母细胞瘤只需要一个单一基因失活,而导致肾母细胞瘤发生的生物学途径很复杂,可能涉及多个基因位点。这些基因位点包括位于11号染色体短臂上的两个基因;一个位于11p13(肾母细胞瘤抑制基因WT1),另一个位于11p15(假定的肾母细胞瘤抑制基因WT2)。除了这两个基因外,1号染色体短臂、7号染色体短臂、16号染色体长臂、17号染色体短臂(p53肿瘤抑制基因)和19号染色体长臂(假定的家族性肾母细胞瘤基因FWT2)上的基因位点也被认为含有与肾母细胞瘤生物学相关的基因。本文对这些基因位点进行了综述,并总结了它们的临床意义。